ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BIOS BioPlus Acquisition Corporation

10.795
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
BioPlus Acquisition Corporation NASDAQ:BIOS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.795 10.79 11.28 0 01:00:00

BioScrip To Host 2016 Third Quarter Results Call

17/10/2016 4:34pm

GlobeNewswire Inc.


BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more BioPlus Acquisition Charts.

BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2016 third quarter financial results on Monday, November 7, 2016, after the close of the U.S. financial markets.

Daniel E. Greenleaf, President and Chief Executive Officer, and Jeffrey M. Kreger, Senior Vice President, Chief Financial Officer and Treasurer, will conduct a conference call as follows:

DateTuesday, November 8, 2016
Time11:00 a.m. Eastern Time
Toll free (U.S.)(888) 372-9592
Webcast (live and replay)www.bioscrip.com

A replay of the conference call will be available for one week after the call's completion by dialing (855) 859-2056 (US) and entering conference call ID number 1061955.

About BioScrip, Inc.BioScrip, Inc. is a leading national provider of infusion and home healthcare management solutions. BioScrip partners with healthcare providers, including physicians, hospital systems, skilled nursing facilities, and with healthcare payors to provide patients better access to high quality, efficient post-acute care services. BioScrip operates with a commitment to bring infusion therapy services into the home or alternate-site settings. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.

Contact:
Jeffrey M. Kreger
Chief Financial Officer 
T:  (720) 697-5200
jeffrey.kreger@bioscrip.com

1 Year BioPlus Acquisition Chart

1 Year BioPlus Acquisition Chart

1 Month BioPlus Acquisition Chart

1 Month BioPlus Acquisition Chart

Your Recent History

Delayed Upgrade Clock